Short communication · 2020
Conference abstractPublished 17 Aug 2015
Formulation of Iron coated Liposomes of SERM and design development of magnetic belt for the management of breast cancer during earlier stages and protection from invasive cancer
SRK Pharmaceutical, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Breast cancer remains the utmost common invasive cancer and the second leading cause of cancer mortality for women in the United States. Worldwide, breast cancer comprises 22.9% of all cancers (excluding non-melanoma skin cancers) in the women. It is estimated that globally over 508000 women died in 2011 due to breast cancer (Global Health Estimates, WHO 2013). Liposomes are attractive due to their unique opportunities together with negligible side effects not only in cancer but also in the treatment of other diseases. In this study our aim is to develop combined prospective of Iron coated Liposomes (of Raloxifene Hydrochloride) and design a magnetic belt (magnetism < 0.1 T) for the management of breast cancer during earlier stages and prevention from developing invasive cancer, and osteoporosis in post-menopausal women. Keeping this objective, the present systematic study was focused to design magnetic belt in shape of women’s breast that will contain few magnetic fires having enough magnetism to attract Iron Coated Liposomes only during oral administration of Raloxifene hydrochloride, in order to overcome the poor bioavailability issue with the drug as well. Reloxifene or methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride (a Selective Estrogen Receptor Modulator-SERM) is FDA approved drug and is used to decrease the chance of invasive breast cancer in postmenopausal women who have a high risk for developing the disease or who have osteoporosis. After oral administration of iron loaded liposomes, liposomes will distribute throughout the body through the systemic circulation and while magnetic belt will be on the cancer site (breast) resulting, accumulation of liposomes will be increase on the site because of Iron and magnet intersection. Ultimately drug concentration and absorption will also enhance on the surrounding areas of cancerous cells, hence cancerous cells will be denatured quickly.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Jun 2016
Formulation and delivery of lipophilic drugs to cancer cells by pHLIP® coated liposomes
Conference abstract · 14 Apr 2025
Hypoxia-activated pro-drug for the treatment of pancreatic cancer: Liposomal formulation approach to improve the PK profile of the drug
Conference abstract · 2018
Thermosensitive magnetic liposome nanodrugs for cancer therapy
Research article · 3 May 2019
A Cost Effective Approach to Prepare Pure and PEG Coated Superpara Magnetic Iron Oxide Nanoparticles by Hydrothermal Process
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Prashant S Khemariya”
